Skip to main content

Closed

SCLX: Scilex Holding Company Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+21.1% / yr

Operating margin-817.1%

ROIC230.5%

Financially safe

Stretched

Debt / equity-0.43×

Interest coverage-21.7×

Current ratio0.08×

Scilex Holding Company

SCLXNASDAQ Capital Market·USD·Closed

Scilex Holding Company

SCLXNASDAQ·USD·Closed

$6.67

+0.98%

$6.67

+$0.07 (0.98%)

52W Range

22thpctl

Volume

0.54×avg

Mkt Cap

56.59MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

22thpctl

Volume

0.54×avg

Market Cap

56.59MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings